SEC Form D · filed June 10, 2020
Larimar Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Ross H. Bierkan · Vienna, VAExec · DirectorLawrence E. Collins · Baltimore, MDDirectorCarole Ben Maimon, Md · Bala Cynwyd, PAExec · DirectorMichael Wahl · Brookline, MADirectorAnshuman Vohra · New York, NYExecThomas Hamilton · Bala Cynwyd, PADirectorFrank E. Thomas · Bala Cynwyd, PADirectorMichael Celano · Bala Cynwyd, PAExecBrant Brown · Dallas, TXDirectorJohn Bentley · Cincinnati, OHDirectorMichael C. Weiss · Rye, NYDirectorRob Soni · New York, NYDirectorThomas O. Daniel · Bala Cynwyd, PADirectorMichael Hiles · Cincinnati, OHDirectorPeter Barrett · Bala Cynwyd, PADirectorThomas R. Burbon · Baltimore, MDDirectorJonathan Leff · Bala Cynwyd, PADirectorSignalfire Vss I GP, L.L.C · SAN FRANCISCO, CADirectorNiall C. Mccomiskey · Rye, NYExecKyle Jameson · Lexington, KYDirectorRobert Slater · Cincinnati, OHDirectorKatie Mcclain · Chicago, ILDirectorHomayar Gandhi · Irvine, CAExec · DirectorJoseph Truitt · Bala Cynwyd, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗